Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Dan Peters | 16,22 | 16,22 | 2025-03-27 |
| Avanza Pension | 4,60 | 4,60 | 2025-03-27 |
| Mukhlis Shamon | 3,67 | 3,67 | 2025-03-27 |
| Sparekassen Kronjylland - General Client Account | 1,95 | 1,95 | 2025-03-27 |
| Che Harald Mårten Vågerö | 1,58 | 1,58 | 2025-03-27 |
| Johan Haag | 1,31 | 1,31 | 2025-03-27 |
| Rossen Denmark Aps | 1,19 | 1,19 | 2025-03-27 |
| Nordnet Pensionsförsäkring | 1,10 | 1,10 | 2025-03-27 |
| Inwäst Aps | 1,06 | 1,06 | 2025-03-27 |
| Marianne Stenlund | 1,06 | 1,06 | 2025-03-27 |
